Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
JOURNAL CLUB - Gastroenterology
Proton Pump Inhibitor Use in Patients on Antiplatelet Therapies: A Consensus Approach to Risk Management
October 2011
Editorial Review: Alan Barkun, MD, FRCPC, FACP, FACG Director, Division of Gastroenterology, MUHC-Montreal General Hospital, Professor of Medicine and Surgery, McGill University, Montréal, Quebec The concern that proton pump...
PRIORITY PRESS - 19th United European Gastroenterology Week (UEGW)
Progress in Achieving Therapeutic Goals in the Management of Inflammatory Bowel Disease
Stockholm, Sweden / October 22-26, 2011
Stockholm - At UEGW, discussions of treatment of inflammatory bowel disease (IBD) with anti-tumour necrosis factor α (TNF-α) agents focused both on long-term experience in clinical trials and on the real-life experiences of...
PRIORITY PRESS - 112th Annual Digestive Disease Week
Colon Cancer Prevention: From Prophylaxis in UC Patients to Adequate Bowel Preparation for Colonoscopy
Chicago, Illinois / May 7-10, 2011
Chicago - New data are providing guidance for further improving already important strategies for the prevention of colorectal cancer. As demonstrated here at DDW, in one series of studies, the effort to isolate a therapeutic mechanism which...
PRIORITY PRESS - Inflammatory Bowel Diseases 2011: 6th Congress of the European Crohn’s and Colitis Organisation (ECCO)
Augmenting Treatment Options in Inflammatory Bowel Disease
Dublin, Ireland / February 24-26, 2011
Dublin - Crohn’s disease (CD) and ulcerative colitis (UC), the 2 most common forms of inflammatory bowel disease, present significant challenges in management. The “one size fits all” approach is no longer applicable and treatment is now...
PRIORITY PRESS - Inflammatory Bowel Diseases 2011: 6th Congress of the European Crohn’s and Colitis Organisation (ECCO)
Evolving Role of Biologic Therapy in Ulcerative Colitis
Dublin, Ireland / February 24-26, 2011
In patients with moderate-to-severe Crohn’s disease (CD) who had failed conventional therapy, the landmark SONIC (Study of Biologic and Immunomodulator Naive Patients in Crohn’s Disease) trial showed that patients treated with...
HEALTH ODYSSEY - PEDIATRIC NUTRITION
Nucleotide-fortified Formulas Can Boost Neonate Immunity, Gastrointestinal Tract Maturation
January 2011
Human breast milk is the gold standard by which all other sources of infant nutrition are compared. Amongst its many advantages, it offers considerable immune bene?ts to the newborn baby’s immature immune system. To meet the...
MEDICAL FRONTIERS - 2011 Gastrointestinal Cancer Symposium
Applying Mutation Analysis to Treatment of GIST
San Francisco, California / January 20-22, 2011
Mutations in KIT play the most important role in gastrointestinal stromal tumours (GISTs), according to Dr. Christopher Corless, Oregon Health and Science University, Portland. Much of the influence occurs on exon 11, which accounts for...
PRIORITY PRESS - 2010 Advances in Inflammatory Bowel Diseases
Escalate or Switch? Managing Loss of Response in Inflammatory Bowel Disease
Hollywood, Florida / December 9-12, 2010
Hollywood - Treatment of Crohn’s disease (CD) and ulcerative colitis (UC) is highly individualized, focusing on the amelioration of acute and chronic symptoms and maintenance of remission. Patient responses are also highly individualized,...
PRIORITY PRESS - 2010 Advances in Inflammatory Bowel Diseases
IBD Therapies: Real-world Problems, Practical Solutions
Hollywood, Florida / December 9-12, 2010
Hollywood - Real-world experience with therapies for the inflammatory bowel diseases Crohn’s disease and ulcerative colitis demonstrates that patient responses to currently available treatments or surgical interventions can vary widely....